Browse studies

Find your next paid study

1 recruiting study matching your filters

A Non-Randomized, Open-label Phase II Trial Testing the Activity of XL092 (Zanzalintinib) in Patients With Advanced Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma

This phase II trial tests how well zanzalintinib (XL092) works in treating patients with leiomyosarcoma that has spread from where it first started to other pl…

Metastatic LeiomyosarcomaUnresectable LeiomyosarcomaBone Sarcoma+7 more

Estimated

~$10 – $6,250

Northwestern UniversityNCT06571734